Approved by Health Canada for Both Subcutaneous and Intravenous Formulations to Treat Serious Inflammatory Diseases Health Canada Joins the FDA and the European Commission in Granting Regulatory ...

Fresenius, through its operating company Fresenius Kabi, is broadening its growing biopharma portfolio through a new licensing agreement with South Korea’s SamChunDang Pharm. Under the agreement, ...

Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...

In one of the biggest deals worldwide for a biosimilar brand, Ahmedabad-based Intas agreed to buy Udenyca-the brand name for ...

Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Any differences are carefully ...

Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

Fresenius is a strong buy with a 60% Return on Revenue potential in the next 3 years, driven by earnings growth and strategic ...

INR:9917. fantasy league NanoVision completes RMB 160 million Series B financing led by Sherpa Huidisen, a 5 billion injection product, was the first to apply for ...

INR:7526. peach 777 casino Following K drug, BMS upgraded the O drug assistance plan: 3 self-paid courses will receive assistance Fresenius Kabi and Weifu Pharma ...

INR:9881. european gaming and betting association Pharmacies face these inspections during the epidemic Fresenius Kabi and ...

INR:4411. fortunately meaning in hindi Overview of national medical and health industry financing in March 2020 Breaking the AZ monopoly! Zhengda Tia ...

mumbai cricket team vs tripura cricket team match scorecard Tibet launches Level II response: All those entering Tibet must be quarantined for 14 days Fresenius Kabi and Weifu Pharmaceuticals enter ...